Sukhtian Faisal Ghiath
SEC CIK 1716033 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics, Inc. | Dir | 221.0K | $213.9K | — | 4 | 2021-12-02 | 2026-07-29 |
Most active insiders at OTLK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sukhtian Ghiath M. | Dir, 10% | $7.50M | — |
| 2 | HILZINGER KURT J | Dir | $176.5K | — |
| 3 | Sukhtian Faisal Ghiath | Dir | $150.0K | — |
| 4 | Haddadin Yezan Munther | Dir | $39.1K | — |
| 5 | THURMAN RANDY H | Dir | $2,145 | — |
| 6 | Jahr Robert Charles | CEO, Dir | — | — |
| 7 | KENYON LAWRENCE A | CFO, Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-29 15:19 | 2026-07-29 | OTLK | Outlook Therapeutics, Inc. | Sukhtian Faisal Ghiath | Dir | P - Purchase | $1.05 | +95.4K | 221.0K | +76% | +$100.0K | |
| 2026-05-27 15:29 | 2026-05-27 | OTLK | Outlook Therapeutics, Inc. | Sukhtian Faisal Ghiath | Dir | P - Purchase | $0.4093 | +122.2K | 125.6K | +3,593% | +$50.0K | |
| 2022-10-11 | 2022-10-07 | OTLK | Outlook Therapeutics, Inc. | Sukhtian Faisal Ghiath | Dir | P - Purchase | $1.29 | +30.0K | 68.0K | +79% | +$38.7K | |
| 2021-12-02 | 2021-12-02 | OTLK | Outlook Therapeutics, Inc. | Sukhtian Faisal Ghiath | Dir | P - Purchase | $1.40 | +18.0K | 38.0K | +90% | +$25.2K |
Purchase Sale Sale after option exercise All abbreviations